Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1994-3-9
|
pubmed:abstractText |
Certain inflammatory cytokines and growth factors have been previously shown to interact with glycosaminoglycan moieties of the extracellular matrix (ECM). We have examined the association of the pleiotropic cytokine TNF-alpha with glycoprotein constituents of ECM. TNF-alpha interacted with fibronectin (FN) and laminin, and to a lesser degree with collagen. The major binding site for TNF-alpha on FN was localized to its 30-kDa N-terminal fragment (FN-N') with a Ki in the sub-nM range. The binding of 125I-labeled TNF-alpha to immobilized FN or FN-N' persisted for at least 24 h, and was specifically inhibited by antibodies to FN, mAb directed against the FN-N' domain, unlabeled TNF-alpha, and by the truncated forms of TNF-alpha receptors. Once bound to immobilized FN or FN-N', the cytokine could not be released by the soluble TNF-alpha-receptors, although it could be released by anti-TNF-alpha Ab. TNF-alpha was also found to interact with soluble FN, although with a lower affinity. Similar to the soluble cytokine, the FN-bound TNF-alpha appears to be functional; it augmented the beta 1-integrin-mediated adhesiveness of activated CD4+ human T cells to the glycoprotein. Hence, binding of TNF-alpha to immobilized FN, which modifies its functional accessibility to soluble TNF-alpha receptors, does not abolish but rather may locally restrict its activity. This study suggests that a major ECM glycoprotein can present, in a restricted manner, a functional adhesion-modulating cytokine to immune cells, and that ECM glycoproteins may regulate their intrinsic cell-adhesive properties by associating with cytokines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
152
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1304-13
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7905501-Amino Acid Sequence,
pubmed-meshheading:7905501-Binding, Competitive,
pubmed-meshheading:7905501-Binding Sites,
pubmed-meshheading:7905501-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7905501-Cell Adhesion,
pubmed-meshheading:7905501-Cells, Cultured,
pubmed-meshheading:7905501-Extracellular Matrix Proteins,
pubmed-meshheading:7905501-Fibronectins,
pubmed-meshheading:7905501-Heparin,
pubmed-meshheading:7905501-Humans,
pubmed-meshheading:7905501-Kinetics,
pubmed-meshheading:7905501-Molecular Sequence Data,
pubmed-meshheading:7905501-Protein Binding,
pubmed-meshheading:7905501-Solubility,
pubmed-meshheading:7905501-Tumor Necrosis Factor-alpha
|
pubmed:year |
1994
|
pubmed:articleTitle |
TNF-alpha binds to the N-terminal domain of fibronectin and augments the beta 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein.
|
pubmed:affiliation |
Department of Biophysics and Membrane Research, Weizmann Institute of Science, Rehovot, Israel.
|
pubmed:publicationType |
Journal Article,
In Vitro
|